Want to track CTSO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cytosorbents Corporation (CTSO) Statistics
Valuation metrics
Market Cap 30.64M
Enterprise value 42.97M
Trailing P/E (ttm) -2.43
Forward P/E -
PEG ratio 0.37
Price/Sales (ttm) 0.77
Price/Book (mrq) 13.13
Enterprise Value/Revenue 1.16
Enterprise Value/EBITDA -6.2
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 108.65K
Average volume (90 days) 92.12K
Price summary
52-Week low 0.37
52-Week high 1.39
Beta -
50-Day moving average 0.57
200-Day moving average 0.65
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 5 Dec 2014
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.32%
Operating margin -0.36%
Operational effectiveness
Return on assets -0.29%
Return on equity -1.65%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.59
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.19
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.08
Total debt (mrq) -
Total Debt/Equity (mrq) 8.64
Current ratio (mrq) 1.09%
Book value per share (mrq) 0.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
